News

Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Vertex plan to build on pain drug breakthrough hits hurdles
The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...
Downtown Edmonton office building to be converted to residential units
Floors of unused office space in the Standard Life building on Jasper Avenue will be converted to housing. CTV News Edmonton's Connor Hogg takes a tour.
What To Expect From Vertex Pharmaceuticals’s (VRTX) Q2 Earnings
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to ...